Ballentine Partners, LLC Eli Lilly & CO Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q3 2024
A detailed history of Ballentine Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ballentine Partners, LLC holds 16,981 shares of LLY stock, worth $13.5 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
16,981
Previous 16,380
3.67%
Holding current value
$13.5 Million
Previous $14.8 Million
1.44%
% of portfolio
0.26%
Previous 0.28%
Shares
29 transactions
Others Institutions Holding LLY
# of Institutions
4,011Shares Held
751MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$77.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$58.7 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$52.4 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$40.9 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$26.9 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $756B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...